Attention-deficit/hyperactivity disorder and substance abuse

Elizabeth Harstad; Sharon Levy; Seth D. Ammerman; Pamela K. Gonzalez; Sheryl A. Ryan; Lorena M. Siqueira; Vincent C. Smith; Vivian B. Faden; Gregory Tau; Renee Jarrett; James Baumberger; Katie Crumley

doi:10.1542/peds.2014-0992

Attention-deficit/hyperactivity disorder and substance abuse

Elizabeth Harstad, Sharon Levy, Seth D. Ammerman, Pamela K. Gonzalez, Sheryl A. Ryan, Lorena M. Siqueira, Vincent C. Smith, Vivian B. Faden, Gregory Tau, Renee Jarrett, James Baumberger, Katie Crumley

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Abstract

Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.

Original language	English (US)
Pages (from-to)	e293-e301
Journal	Pediatrics
Volume	134
Issue number	1
DOIs	https://doi.org/10.1542/peds.2014-0992
State	Published - Jul 2014

All Science Journal Classification (ASJC) codes

Pediatrics, Perinatology, and Child Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1542/peds.2014-0992

Cite this

@article{00810031b8564496878b94b533863954,

title = "Attention-deficit/hyperactivity disorder and substance abuse",

abstract = "Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.",

author = "Elizabeth Harstad and Sharon Levy and Ammerman, {Seth D.} and Gonzalez, {Pamela K.} and Ryan, {Sheryl A.} and Siqueira, {Lorena M.} and Smith, {Vincent C.} and Faden, {Vivian B.} and Gregory Tau and Renee Jarrett and James Baumberger and Katie Crumley",

year = "2014",

month = jul,

doi = "10.1542/peds.2014-0992",

language = "English (US)",

volume = "134",

pages = "e293--e301",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "1",

}

TY - JOUR

T1 - Attention-deficit/hyperactivity disorder and substance abuse

AU - Harstad, Elizabeth

AU - Levy, Sharon

AU - Ammerman, Seth D.

AU - Gonzalez, Pamela K.

AU - Ryan, Sheryl A.

AU - Siqueira, Lorena M.

AU - Smith, Vincent C.

AU - Faden, Vivian B.

AU - Tau, Gregory

AU - Jarrett, Renee

AU - Baumberger, James

AU - Crumley, Katie

PY - 2014/7

Y1 - 2014/7

N2 - Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.

AB - Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.

UR - http://www.scopus.com/inward/record.url?scp=84904191407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904191407&partnerID=8YFLogxK

U2 - 10.1542/peds.2014-0992

DO - 10.1542/peds.2014-0992

M3 - Article

C2 - 24982106

AN - SCOPUS:84904191407

SN - 0031-4005

VL - 134

SP - e293-e301

JO - Pediatrics

JF - Pediatrics

IS - 1

ER -

Attention-deficit/hyperactivity disorder and substance abuse

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this